News

Veterans Exploring Treatment Solutions (VETS) Applauds White House Executive Order Advancing Ibogaine Research, Urges Accelerated Scientific Investment

Without Connection, There is Suffering: Chris “CT” Thompson on Healing, Community and the People Who Stay

Green Beret veteran and former VETS grant recipient Chris "CT" Thompson, now VETS' Director of Community Engagement, shares why connection, community, and integration support matter long after treatment.

VETS Celebrates Governor Newsom’s Signing of AB 113, Delivering California’s First-Ever State Investment in Veteran Psychedelic-Assisted Therapy Research

$4.7 million appropriation to the Office of Precision Medicine marks the third consecutive year veteran advocates have advanced psychedelic research legislation in California, one of the largest veteran-specific state investments in U.S. history

Healing Does Not Happen Alone: Dr. Lori Camper on Integration, Family, and Community after Treatment

VETS Programs Director Dr. Lori Camper shares why healing extends beyond treatment, highlighting the importance of integration, family support, community, and intentional daily changes as veterans continue their healing journey at home.

MDMA and the FDA, Take Two

VETS Policy Director Logan Davidson weighs in on Resilient Pharmaceuticals' renewed FDA application for MDMA-assisted therapy, calling it a meaningful step toward the rigorous, science-backed treatment options veterans with treatment-resistant PTSD deserve.

Legislative Progress Q2 2026: Building the Infrastructure for What Comes Next

A look at Q2 2026's legislative progress on veteran access to psychedelic-assisted therapy, from new state research funding and trigger laws to a federal Executive Order and VETS-led advocacy days at statehouses in North Carolina and Massachusetts.

Understanding the Healing Journey: Dr. Lori Camper on Preparation, Integration, and What Comes After Psychedelic-Assisted Therapy

In this conversation, VETS Programs Director Dr. Lori Camper shares what preparation, integration, and support truly look like for veterans exploring psychedelic-assisted therapy, and why the work that happens before and after treatment matters just as much as the experience itself.

VA Benefits: Trump Shares Update on Psychedelic Drug Treatment for Veterans

President Trump announced that HHS Secretary RFK Jr. received the University of Miami's original 1994 ibogaine FDA application to accelerate psychedelic research access for veterans, with VETS co-founder and CEO Amber Capone comments that "veterans need to understand that these treatments are not for everyone and they need careful screening, medical oversight, preparation, and follow-up."

VETS Applauds Massachusetts House Passage of Psychedelic-Assisted Therapy Pilot Program

Veteran Advocates Thank House Leadership for Advancing Landmark Legislation and Urge the Senate to Retain the Provision in Economic Development Bill

The Second Homecoming: What Freedom Means After Service

This blog explores how true freedom after military service is found in healing, reconnection, and the ongoing journey home for veterans and their families.